FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Traweek James W JR
2. Issuer Name and Ticker or Trading Symbol

REATA PHARMACEUTICALS INC [ RETA ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    __X__ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

C/O CPMG, INC., 2000 MCKINNEY AVE., SUITE 2125
3. Date of Earliest Transaction (MM/DD/YYYY)

11/18/2019
(Street)

DALLAS, TX 75201
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A common stock 11/18/2019  P  40218 A$183 3063567 I See Footnote (1)(7)
Class A common stock         16645 I By JET Land & Cattle Company, Ltd. (2)(7)
Class A common stock         7056 I By 1 Thessalonians 5:18 Trust (3)(7)
Class A common stock         572 I By Esme Grace McGaughy Trust (4)(7)
Class A common stock         572 I By Mary Frances McGaughy Trust (5)(7)
Class A common stock         2739 I See footnote (6)(7)
Class A common stock         35 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:
(1) These shares of Class A common stock are held in various funds for which CPMG, Inc. serves as investment manager. The Reporting Person is a co-director and co-shareholder of CPMG, Inc.
(2) The Reporting Person is the sole owner of the general partner of JET Land & Cattle Company, Ltd.
(3) The Reporting Person is trustee of 1 Thessalonians 5:18 Trust.
(4) The Reporting Person is trustee of Esme Grace McGaughy Trust.
(5) The Reporting Person is trustee of Mary Frances McGaughy Trust.
(6) These shares of Class A common stock are held in escrow for a charitable donee by American Stock Transfer & Trust Company, LLC.
(7) The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Traweek James W JR
C/O CPMG, INC.
2000 MCKINNEY AVE., SUITE 2125
DALLAS, TX 75201

X


Signatures
/s/ James W. Traweek, Jr.11/18/2019
**Signature of Reporting PersonDate

Reata Pharmaceuticals (NASDAQ:RETA)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Reata Pharmaceuticals Charts.
Reata Pharmaceuticals (NASDAQ:RETA)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Reata Pharmaceuticals Charts.